1. Tomatidine, a tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in apoE-deficient mice by inhibiting acyl-CoA:cholesterol acyl-transferase (ACAT).
- Author
-
Fujiwara Y, Kiyota N, Tsurushima K, Yoshitomi M, Horlad H, Ikeda T, Nohara T, Takeya M, and Nagai R
- Subjects
- Animals, Apolipoproteins E genetics, Atherosclerosis enzymology, Atherosclerosis genetics, Atherosclerosis metabolism, Cell Line, Cholesterol Esters metabolism, Cricetinae, Disease Models, Animal, Female, Foam Cells metabolism, Humans, Hyperlipidemias enzymology, Hyperlipidemias genetics, Hyperlipidemias metabolism, Mice, Mice, Inbred C57BL, Mice, Knockout, Sterol O-Acyltransferase genetics, Sterol O-Acyltransferase metabolism, Tomatine administration & dosage, Apolipoproteins E deficiency, Atherosclerosis drug therapy, Down-Regulation, Hyperlipidemias drug therapy, Solanum lycopersicum chemistry, Plant Extracts administration & dosage, Sterol O-Acyltransferase antagonists & inhibitors, Tomatine analogs & derivatives
- Abstract
It was previously revealed that esculeoside A, a new glycoalkaloid, and esculeogenin A, a new aglycon of esculeoside A, contained in ripe tomato ameliorate atherosclerosis in apoE-deficent mice. This study examined whether tomatidine, the aglycone of tomatine, which is a major tomato glycoalkaloid, also shows similar inhibitory effects on cholesterol ester (CE) accumulation in human monocyte-derived macrophages (HMDM) and atherogenesis in apoE-deficient mice. Tomatidine significantly inhibited the CE accumulation induced by acetylated LDL in HMDM in a dose-dependent manner. Tomatidine also inhibited CE formation in Chinese hamster ovary cells overexpressing acyl-CoA:cholesterol acyl-transferase (ACAT)-1 or ACAT-2, suggesting that tomatidine suppresses both ACAT-1 and ACAT-2 activities. Furthermore, the oral administration of tomatidine to apoE-deficient mice significantly reduced levels of serum cholesterol, LDL-cholesterol, and areas of atherosclerotic lesions. The study provides the first evidence that tomatidine significantly suppresses the activity of ACAT and leads to reduction of atherogenesis.
- Published
- 2012
- Full Text
- View/download PDF